Upcoming Events
Log In
Pricing
Free Trial

Oropharynx - Palatine Tonsil SCC: Paths of Spread

HIDE
PrevNext

0:01

Hello everyone.

0:02

Dr. Sidney Levy here.

0:03

Today, I'm continuing our discussion of the diagnosis

0:06

and staging of oropharyngeal squamous cell malignancy,

0:11

using the example of a palatine tonsillar tumor.

0:14

So, this large tumor can spread in multiple directions.

0:19

Common methods of spread are via the

0:22

glossotonsillar sulcus into the base of the tongue.

0:26

So in this case, the tumor is threatening to

0:29

do this, but if we look at the base of tongue here,

0:33

and we come out to the tonsillar tumor,

0:37

we can see that the glossotonsillar sulcus

0:41

is effaced because of the size of the tumor.

0:46

So, normally the glossotonsillar sulcus is easier

0:49

to appreciate in this region here, but in this

0:52

case, the tumor is very large, and it's effaced it.

0:55

We suspect that there may be microscopic

0:58

invasion of the base of the tongue, but we can't

1:01

actually confirm for certain that there

1:04

is macroscopic extension on these images.

1:08

But that is a common method of spread.

1:10

The other method of spread is laterally

1:12

into the deep spaces of the neck.

1:14

And specifically, the masticator space is one

1:17

that we pay a lot of attention to because

1:20

it has an important influence on staging.

1:24

So in this particular case, the tumor,

1:28

once again, is close to the masticator

1:30

space, but not clearly invading it.

1:33

Let me draw that for you

1:35

so we're all on the same page.

1:37

This is the masticator space here.

1:40

We have the masseter muscle and

1:43

the medial pterygoid muscle.

1:46

And then we have the tumor effacing

1:49

the parapharyngeal fat in this region.

1:53

But we can still see the margin

1:55

of the medial pterygoid clearly.

1:58

So, this tumor, while close to the masticator space,

2:02

is not clearly invading into it.

2:05

The other direction these tumors can

2:07

take is superiorly into the soft palate.

2:10

And for that, a combination of the axial and

2:12

the sagittal is probably the best way to go.

2:15

So, just to orient you, we have the uvula

2:18

of the soft palate here, on the sagittal.

2:21

And then as we come out into the tumor, we can see

2:25

that the tumor is very close to the soft palate.

2:30

So, once again, uvula in the axial plane,

2:37

and the uvula as we go down into the rest of the soft

2:40

palate becomes continuous with the palatine tonsil.

2:44

There is some concern here that the tumor is

2:47

very close to the soft palate, and there would be

2:50

suspicion that this is invading the soft palate.

2:53

So that's an important consideration as well.

2:56

The last thing I would like to finish off

2:58

with is differentials to consider in this

3:01

region, and perhaps the most common one would

3:04

be palatine tonsillar lymphoid hyperplasia.

3:08

For that, it's important to remember that hyperplasia

3:11

is usually smooth enlargement, mild enlargement,

3:18

and often symmetrical or almost symmetrical.

3:21

So, it's not a consideration here because

3:24

there is clearly a mass, and there is a large

3:26

difference in size between the two tonsils.

3:31

Other things to consider are lymphoma, which can be

3:34

difficult to distinguish, but tends to have a more

3:38

smooth margin and homogeneous signal intensity.

3:46

And also other considerations such as

3:49

infection, such as a peritonsillar abscess,

3:51

or there can also be benign mixed tumors in

3:55

this region, such as pleomorphic adenomas.

3:59

Minor salivary gland malignancy

4:01

tends to be uncommon in this area

4:05

but can also be identified, usually

4:07

by the pathologist rather than us.

4:11

In our next vignette, I'd like to go on

4:13

and formally stage this palatine tonsillar

4:16

malignancy using TNM staging according to

4:20

the most recent AJCC 8th edition guidelines.

Report

Description

Faculty

Sidney Levy, PhD, MBBS

Radiologist and Nuclear Medicine Specialist

I-MED

Tags

Oral Cavity/Oropharynx

Neuroradiology

Neuro

Neoplastic

MRI

Infectious

Head and Neck